Related Experiment Video
Updated: Jun 3, 2026
10:44
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
The immunopathophysiology of multiple sclerosis.
Gregory F Wu1, Enrique Alvarez
1Division of Multiple Sclerosis, Department of Neurology, Washington University, Box 8111, 660 South Euclid Avenue, St Louis, MO 63110, USA. wug@neuro.wustl.edu
Neurologic Clinics
|March 29, 2011
Summary
This review details the immunopathology of multiple sclerosis (MS), focusing on relapsing-remitting MS. It examines central nervous system inflammation, B-cell roles, and neuroaxonal damage in MS pathogenesis.
Area of Science:
- Neuroimmunology
- Pathology
- Central Nervous System Inflammation
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS).
- Understanding the immunopathogenesis of MS is crucial for developing effective treatments.
- Relapsing-remitting MS (RRMS) is the most common form, characterized by distinct neurological episodes.
Purpose of the Study:
- To review the key features of MS immunopathology, with a specific focus on RRMS.
- To discuss emerging concepts in MS pathogenesis.
- To integrate current pathological findings with evolving understanding of disease mechanisms.
Main Methods:
- Literature review of immunopathology in multiple sclerosis.
- Focus on human MS pathology, excluding animal models like experimental autoimmune encephalomyelitis (EAE).
- Characterization of cytokine networks and immune cell involvement.
Main Results:
- Inflammatory damage in the CNS is mediated by complex cytokine networks.
- B-cell involvement plays a significant role in MS pathogenesis.
- Axonal and neuronal damage are key features of MS pathology.
Conclusions:
- Emerging concepts in MS pathogenesis involve intricate interactions within the immune system.
- Targeting specific cytokine networks and B-cell pathways may offer therapeutic strategies for MS.
- Further research into CNS inflammatory damage is essential for improving MS management.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:40Cell-mediated Immune Responses
Overview
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...